PGNY PROGYNY INC
2026Q1 · CUSIP 74340E103 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
284
Δ holders QoQ
-28
Breadth percentile
Top 95%
Whale holders
148
Δ whales
-4
Inst. holding value
$1.2B
New positions
41
Closed positions
69
Price momentum (1Q)
+18.2%
Put / Call
2/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 10 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q1 | Top 9% | +5.8% | +24.7% |
| 2023Q3 | Top 15% | +28.7% | -10.8% |
| 2023Q2 | Top 4% | -17.0% | +7.8% |
| 2022Q3 | Top 2% | -2.2% | +8.1% |
| 2021Q2 | Top 1% | +32.3% | -11.2% |
| 2021Q1 | Top 14% | -12.6% | +15.7% |
| 2020Q4 | Top 14% | +6.4% | -7.1% |
| 2020Q3 | Top 12% | +65.2% | +86.7% |
| 2020Q2 | Top 7% | +4.0% | +67.3% |
| 2020Q1 | Top 11% | +6.8% | +11.0% |
Options Sentiment
Put holders
2
QoQ: +1
Call holders
3
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
41.5
EPS (TTM)
$0.77
EPS YoY
+35.1%
Revenue (TTM)
$1.3B
Revenue YoY
+6.6%
Net margin
5.2%
ROE
15.4%
Debt ratio
37.1%
FCF (TTM)
$184M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.